Cimetidine may improve survival in colorectal cancer
the ONA take:
According to new research published in the journal ecancermedicalscience, cimetidine, a histamine-2 receptor antagonist (H2RA), can improve survival in colorectal cancer.
Researchers from the Repurposing Drugs in Oncology (ReDO) project have found that cimetidine has positive effects in colorectal cancer, gastric cancer, melanoma, and renal cell carcincoma. Cimetidine would be an effective repurposed drug for cancer as it is very safe and has preclinical and clinical evidence of effectiveness for numerous types of cancer.
Furthermore, cimetidine is cheap and available over-the-counter. Cimetidine, like famotidine and ranitidine, works by inhibiting histamine receptors in the stomach, thereby decreasing the production of gastric acid.
The ReDO project has also found evidence of anti-cancer properties among clarithromycin, diclofenac, mebendazole, nitroglycerin, and itraconazole. Their findings suggest that these anti-cancer properties should be studied in clinical trials, but pharmaceutical companies lack the financial incentives to do so.
They note that repurposed drugs that are accessible, cheap, and have limited adverse effects are good alternatives to treat cancer in low- and middle-income countries and could reduce costs of treating cancer in developed countries.
Cimetidine, a histamine-2 receptor antagonist (H2RA), can improve survival in colorectal cancer.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|